Home / Health / Blindness, Ruptured Colon: Lawsuits Target Ozempic
Blindness, Ruptured Colon: Lawsuits Target Ozempic
28 Jan
Summary
- Lawsuits allege GLP-1 drugs caused blindness and colon rupture.
- Thousands of patients are suing Ozempic and Mounjaro makers.
- Drug companies deny allegations, defend drug safety profiles.
Lawsuits are mounting against manufacturers of GLP-1 weight-loss drugs, including Ozempic and Mounjaro, with plaintiffs alleging severe health consequences. Cases describe a Maryland truck driver blinded by an "eye stroke," a Louisiana woman suffering brain dysfunction after weeks of vomiting, and an Oklahoma woman whose colon ruptured.
These suits, now numbering at least 4,400 and consolidated into federal and state litigation expected to take years, claim drugmakers like Novo Nordisk and Eli Lilly did not sufficiently warn about risks. The drugs, mimicking a hormone to slow digestion and increase fullness, have surged in popularity for diabetes and obesity management.
Drug companies broadly refute these allegations, asserting the drugs' safety profiles are well-established through extensive trials and real-world use, with known risks detailed in FDA-approved labeling. However, plaintiffs' attorneys argue that current warnings do not fully disclose the range of potential severe outcomes.
